Αρχική World News A vision for the next decade of UK life sciences

A vision for the next decade of UK life sciences

It may set a bold ambition to increase funding for UK life science – but what could the government’s Life Sciences Vision mean for cancer research? Here we summarise the plan and find out how Cancer Research UK influenced its formation.

The UK Government recently published its Life Sciences Vision which sets out how the UK can build on its status as a global leader in life sciences to diagnose, treat, cure and prevent disease.

A healthy life sciences environment is critical to maximise the impact of Cancer Research UK’s research and drive progress to see 3 in 4 people with cancer surviving the disease by 2034. Michelle Mitchell, Cancer Research UK CEO, was part of the advisory group steering the Vision. She was successful in highlighting what is important for cancer and the vital role medical research charities will play to ensure the UK can deliver on the Vision’s ambitions.

“We’re pleased to see the commitments made to boosting early diagnosis and treatment for cancer, areas that we have pioneered as we know they will make a big impact for patients,” she said. “Backed by the right investment, this vision will set the UK apart as a world leader in life sciences and cancer research, which will drive scientific innovation and, ultimately, save lives.”

Key points in the Vision

Building on the 2017 Life Sciences Industrial Strategy, the Vision provides a 10-year view from the Government of its plans to stimulate the UK’s life sciences sector and focuses on how some of the most significant health challenges will be addressed, including cancer.

The Vision has four themes (including clinical research); seven healthcare missions (cancer is one); and four preconditions for success (NHS as an innovation partner; growing investment in science and research; governance and oversight of NHS health data; and access to finance).

There is a welcome emphasis on the early diagnosis and treatment of disease throughout the Vision.

Specific cancer healthcare challenge highlights:

  • The UK has the potential to act as a testbed for oncology innovation with the right focus on developing and commercialising new medicines, diagnostics and technologies. CRUK set out the challenges and potential solutions to commercialising early detection and diagnosis technologies in our Early Detection and Diagnosis of Cancer Roadmap, which we shared with key parts of the Government during the development of the Vision.
  • A focus on immunotherapies and cancer vaccines.
  • Recognition that cancer is a global challenge that no country can solve alone, with the recently announced UK-US Cancer Summit mentioned and its role in sharing ideas and stimulating collaboration to advance progress.

Ambitions in the Vision’s section on clinical research are also welcome, with aims to make the NHS “fully research ready”. These ambitions support recommendations in CRUK’s report on NHS research, Creating Time for Research. “We’re pleased to see the commitments made to boosting early diagnosis and treatment for cancer, areas that we have pioneered as we know they will make a big impact for patients,” said Michelle.

Clinical research highlights:

  • To embed clinical research and innovation in the NHS, bolster capacity and create a research-positive culture – including expectations on leaders to encourage research, steps to create capacity and incentives, monitoring and reporting of activity within the NHS, and embedding research in standards for registered professionals.
  • To make the UK the leading global centre for innovative research design and delivery – with a focus on clinical trials set up and delivery, noting the need to build on…on the G7 Clinical Trials Protocol.
  • To cut bureaucracy and red tape to create a more efficient and effective research environment.
  • To ensure the UK remains a financially attractive location for research and development.
  • To reflect the diversity of the UK’s population in future clinical research.

There is much to be welcomed in the plans and their ambitions to enhance and grow the life sciences sector. However, the plans are high level and provide strategic direction rather than setting out specific programmes – spending commitments will be needed in the next Government Spending Review to ensure priorities are delivered on.

The Vision also recognises that NHS health data will be a fundamental factor and emphasises that success can only be achieved with the full support of patients, the public and the NHS.

The important role of medical research charities is mentioned throughout the Vision, demonstrating that our role in this shared endeavour is recognised. Translating the Vision’s ambitions into reality will rely on investment and partnership across all parts of the UK’s diverse research environment – Cancer Research UK will play a vital role and we need to work collectively with industry, academia and Government.

Read Michelle’s perspective on the Vision here

Read the Life Science Vision here

Zoë Martin is a Policy Manager at Cancer Research UK

More on this topic



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Puppy That Was Born Dead Becomes Therapy Dog for Cancer Patient

This story has been shared as part of the Fur Fam Story Contest. You can submit your own tale through December 5th. Voting will...

ESMO Immuno-Oncology Congress 2021, Geneva, Switzerland, 8-11 December

LUGANO, Switzerland – The ESMO Immuno-Oncology Congress 2021, the European platform dedicated to the development and use of immunotherapies for cancer treatment, will be held...

Targeted drug recommended to treat some advanced lung cancer patients

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer. Non small cell lung cancer cells. The National Institute...

Withdrawal of Application to Change the EU Marketing Authorisation for Cervarix

The European Medicines Agency (EMA) announced on 12 November 2021 that GlaxoSmithKline Biologicals SA withdrew its application to use Cervarix (human papillomavirus vaccine ...

Robin Williams Required Film Companies He Worked With To Hire Homeless People

It’s been years since his passing, but the world still feels the loss of Robin Williams. Not only was he an extremely talented and funny...

Though the Pandemic Has Slowed, Many Are Still Struggling to Put Food on the Table

The COVID-19 pandemic wreaked havoc on the economy, leaving many people who had been comfortable suddenly struggling financially. Feeding America estimates that at least...